Nature Methods Names Cryo-Electron Microscopy “Method of the Year 2015”
20 January 2016 - 12:20AM
FEI (NASDAQ:FEIC) is pleased to announce that cryo-electron
microscopy (cryo-EM) has been named “Method of the Year 2015” by
Nature Methods, in a Special Feature of the January 2016 issue:
http://www.nature.com/nmeth/focus/moy2015/index.html
(doi:10.1038/nmeth.3730).
“State-of-the-art cryo-electron microscopes are impacting
biomedical research like never before, delivering atomic-level,
three-dimensional structures of medically-important proteins to
university and pharmaceutical company scientists with unprecedented
speed and accuracy,” said Professor Stephen K. Burley, M.D., D.
Phil. Director of the RCSB Protein Data Bank and Distinguished
Professor of Chemistry and Chemical Biology at Rutgers, The State
University of New Jersey. “Over the next few years, these new
instruments will enable the power of structure-guided drug
discovery to be brought to bear on entirely new classes of
disease-causing proteins, particularly those responsible for
neurological and psychiatric illnesses where there remain enormous,
unmet medical needs,” added Burley.
“Nature Methods’ recognition of cryo-EM as ‘Method of the Year
2015’ is an extremely prestigious award within the life science
research community,” said Peter Fruhstorfer, vice president and
general manager of the Life Sciences business, FEI. “We are deeply
gratified to know that our investments in developing and
commercializing the technique are paying important dividends in
scientific advancements that have the potential to benefit the
well-being of all.”
Biologists use cryo-EM to study the structure and function of
cells, viruses and protein assemblies at the molecular,
sub-nanometer scale. Recent technological advancements in the
microscope design and imaging hardware, along with enhanced image
processing and automation, have helped to catapult the technique’s
success. Many leading scientists have recently adopted the
technique as one of the most critical tools in their laboratory.
Established methods for structure determination, such as x-ray
crystallography and nuclear magnetic resonance spectroscopy, are
now routinely integrated with cryo-EM density maps to achieve
atomic-resolution models of complex, dynamic molecular
assemblies.
Fruhstorfer adds, “FEI pioneered cryo-EM with its introduction
of the Titan Krios™ transmission electron microscope in 2008. Since
then, we have continued to make advancements in the technology and
have partnered with several leading scientists to develop a sample
preparation and imaging workflow that has potentially game changing
power in structural and cellular biology.”
More information about cryo-EM can be found at
http://www.fei.com/life-sciences/.
About FEIFEI Company (Nasdaq:FEIC) designs,
manufactures and supports a broad range of high-performance
microscopy workflow solutions that provide images and answers at
the micro-, nano- and picometer scales. Its innovation and
leadership enable customers in industry and science to increase
productivity and make breakthrough discoveries. Headquartered in
Hillsboro, Ore., USA, FEI has over 2,800 employees and sales and
service operations in more than 50 countries around the world. More
information can be found at: www.fei.com.
FEI Safe Harbor Statement This news release
contains forward-looking statements that include statements
regarding the performance capabilities and benefits of the Titan
Krios TEM and cryo-EM workflow solution. Factors that could affect
these forward-looking statements include but are not limited to our
ability to manufacture, ship, deliver and install the tools,
solutions or software as expected; failure of the product or
technology to perform as expected; unexpected technology problems
and challenges; changes to the technology; the inability of FEI,
its suppliers or project partners to make the technological
advances required for the technology to achieve anticipated
results; and the inability of the customer to deploy the tools or
develop and deploy the expected new applications. Please also refer
to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the
U.S. Securities and Exchange Commission for additional information
on these factors and other factors that could cause actual results
to differ materially from the forward-looking statements. FEI
assumes no duty to update forward-looking statements.
For more information contact:
Sandy Fewkes (media contact)
MindWrite Communications, Inc.
+1 408 224 4024
sandy@mind-write.com
FEI
Jason Willey (investors and analysts)
Sr. Director, Investor Relations & Corporate Development
+1 503 726 2533
jason.willey@fei.com
Fei Company (MM) (NASDAQ:FEIC)
Historical Stock Chart
From Apr 2024 to May 2024
Fei Company (MM) (NASDAQ:FEIC)
Historical Stock Chart
From May 2023 to May 2024